Early Myocardial Dysfunction and Benefits of Cardiac Treatment in Young X-Linked Duchenne Muscular Dystrophy Mice.
Marie VincentiCharlotte FarahPascal AmedroValerie ScheuermannAlain LacampagneOlivier CazorlaPublished in: Cardiovascular drugs and therapy (2021)
This is the first animal study to evaluate the therapeutic effect of a drug targeting early onset of DMD-related cardiomyopathy, using 2D strain echocardiography. Speckle-tracking analyses revealed early alterations of LV posterior segments that could be prevented by 4 months of RyR2 stabilization.